Press release
Infectious Disease Diagnostics Market is projected to surpass USD 30.9 billion by 2031 | Danaher Corporation (US), Becton, Dickinson and Company (US)
Infectious Disease Diagnostics Market
To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS10304
A contagious illness A diagnostic is a laboratory test carried out by trained technicians and medical professionals to identify infectious diseases. It is a diagnostic process used to characterize and identify the infectious disease's causal organism. By using a variety of diagnostic techniques and tools, the sample of urine, blood, mucus, or other body fluids is examined to provide details on the causative organism.
Market Trends and Drivers
The market for infectious disease diagnostics will rise as a result of the prevalence of infectious diseases in both developed and emerging nations. The growing number of prescriptions for infectious illness diagnostic tests is due to the diagnosis and treatment of such disorders. The demand for infectious disease diagnostics is anticipated to increase during the projected period as a result of these factors and the expanding trend toward preventive medicine. The extensive population-based testing is necessary to enhance COVID-19 preventive and control activities. Since infectious disease diagnostics performs these tests, it had a favorable effect on this market.
Report Overview- https://www.globalinsightservices.com/reports/infectious-disease-diagnostics-market
Similarly, Major participants in the infectious illness diagnostics market are anticipated to have chances for expansion in emerging economies like India, South Korea, Brazil, and Mexico. This can be linked to the high disease prevalence, sizable patient population, expanding medical tourism, improving healthcare infrastructure, and rising disposable income in these nations. The Asia Pacific region has become a flexible and business-friendly hub because to fewer onerous rules and data requirements than the previously mentioned criteria.
Market Restraints and Challenges
One of the main factors limiting the growth of the infectious illness diagnostics industry is inadequate reimbursement. Getting health insurance to pay for the tests is a significant obstacle that the majority of diagnostic companies confront when trying to commercialize their tests.
Major Players in the Global Infectious Disease Diagnostics Market
The key players studied in the report are Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Siemens Healthineers AG (Germany), Danaher Corporation (US), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Hologic, Inc. (US), QIAGEN N.V. (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), and Ortho Clinical Diagnostics Holdings plc (US), among others.
Get A Customized Scope to Match Your Need Ask an Expert - https://www.globalinsightservices.com/request-customization/GIS10304
COVID-19 Impact
The new coronavirus is the infectious disease known as COVID-19. Before the outbreak started in Wuhan, China, in December 2019, COVID-19 was largely unknown. In just a few weeks, it went from a local issue to a worldwide pandemic. On March 11, 2020, the World Health Organization (WHO) designated COVID-19 to be a pandemic. Government agencies from all over the world are assisting laboratories in expediting COVID-19 testing procedures because testing is still an essential step in slowing the disease's rapid spread. Due to the employment of infectious disease diagnostic techniques for COVID-19 testing, the COVID-19 pandemic had a beneficial influence on the market for infectious illness diagnostics but had a negative impact on total sales for the majority of the companies.
Accordingly, regulatory agencies used techniques to hasten the licensing of COVID-19 diagnostic products. As diagnostic testing continues to be the foundation of the COVID-19 response, supporting containment efforts to reduce the outbreak, significant companies have also made strategic developments to deploy COVID-19 quick tests and neutralize the influence of COVID-19 on their operating capabilities. Additionally, due to the severity of the crisis and growing capacity problems with PCR-based testing, diagnostic solutions were developed more quickly to fulfill the demand for mass testing. Major players in this industry expanded their operations to test and monitor COVID-19.
Global Infectious Diseases Diagnostics Market Segmentation
By Product & Services
Assays, Kits & Reagents
Instruments
Services & Software
By Technology
Immunodiagnostics
Clinical Microbiology
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Technology
DNA Sequencing and Next Generation Sequencing
DNA Microarray
Others
By Disease Type
Hepatitis
Human Immunodeficiency Virus
Chlamydia Trachomatis Genital Infection & Gonorrhea
Hospital Acquired Infections
Human Papillomavirus
Tuberculosis
Influenza
Others
By End Use
Hospital/Clinical Laboratories
Reference Laboratories
Others
Buy Now - https://www.globalinsightservices.com/checkout/single_user/GIS10304
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
New Report Published by Global Insight Services : https://www.globalinsightservices.com/reports/hydrogen-projects-database/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infectious Disease Diagnostics Market is projected to surpass USD 30.9 billion by 2031 | Danaher Corporation (US), Becton, Dickinson and Company (US) here
News-ID: 3085957 • Views: …
More Releases from Global Insight Services
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved…
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the…
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview
Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger…
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview
Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
